Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab

DOI: https://doi.org/10.1177/24755303231195884

Abstract:[This corrects the article DOI: 10.1177/24755303211029598.].

What problem does this paper attempt to address?

Comparison of exertion required to perform standard and active compression-decompression cardiopulmonary resuscitation.

J. J. Shultz,M. Mianulli,T. Gisch,P. Coffeen,G. Haidet,K. Lurie

DOI: https://doi.org/10.1016/0300-9572(94)00812-T

IF: 6.251

1995-02-01

Resuscitation

Abstract:
Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

DOI: https://doi.org/10.1177/24755303231195864

Abstract:[This corrects the article DOI: 10.1177/2475530320925067.].
Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series

DOI: https://doi.org/10.1177/24755303231195857

Abstract:[This corrects the article DOI: 10.1177/2475530321995516.].
Depth profiling the whispering gallery modes in TiO2:Eu3+ microspheres using cathode luminescence.

M. Tomita,H. Ikari,H. Mimura,Takahiro Matsumoto

DOI: https://doi.org/10.1364/OL.33.000336

IF: 3.6

2008-02-15

Optics Letters

Abstract:The depth-resolved luminescence of whispering gallery modes (WGMs) was studied in TiO2:Eu3+ microsphere using cathode luminescence. As the penetration depth of the electron beam into the microsphere was increased through the control of the accelerating voltage, periodic structures appeared superimposed over the intrinsic transition lines of Eu3+, which were attributable to the cavity enhancement effect of the spontaneous emission by WGM resonance. The calculated radial intensity distribution of the WGM and the penetration depth explained the observed dependence of the WGM structure's visibility on the accelerating voltage.
Corrigendum to Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data

DOI: https://doi.org/10.1177/24755303231195882

Abstract:[This corrects the article DOI: 10.1177/24755303221077211.].
Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers.

D. Drachenberg,Othon J. Mena,P. Choyke,W. Linehan,M. Walther

DOI: https://doi.org/10.1097/01.JU.0000130930.70356.28

2004-07-01

Abstract:PURPOSE Nephron sparing surgery has become accepted surgical practice for removing of renal tumors. The resection of central lesions has been thought to be more surgically challenging than that of peripheral tumors. We analyzed our experience with renal preservation surgery in patients with small hereditary central renal tumors. MATERIALS AND METHODS From 1992 to 2000 we performed 116 partial nephrectomies with 44 kidneys (38%) demonstrating central renal masses. Central renal tumors were defined radiologically as those completely encircled by parenchyma or transgressing the interpapillary line on computerized tomography. We compared this group to a similar series of 67 patients with hereditary renal cancer with only peripheral based tumors. RESULTS Mean tumor size was 3.2 cm (range 1.5 to 7.5). Mean operative time was 352 minutes (range 70 to 830). Renal hypothermia and vascular clamping were used in 19 of 44 procedures (41%). Mean ischemic time was 55 minutes (range 16 to 143). Mean blood loss was 4.6 l (range 0.1 to 23). The complication rate was 23% (10 of 44 cases) and with 18% (8 of 44) directly related to surgical technique. The mean transfusion requirement was 6.7 U (range 0 to 32) and 12 of 44 procedures (27%) required no blood products. Mean preoperative and postoperative serum creatinine was 1.05 (range 0.6 to 1.8) and 1.08 mg/dl (range 0.6 to 2.1), respectively. Mean followup was 33.7 months. No metastasis developed during followup. CONCLUSIONS Central renal tumors are a common manifestation of hereditary renal cell carcinoma. There was no statistical difference found between common operative parameters when central and peripheral nephron sparing surgeries were compared. However, mean operative blood loss and transfusion requirements were increased in the central tumor group.
Newly-Built Iterative Receiver and Hardware Implementation for V-BLAST

Rong Chen,Xun Fan,Youyun Xu,Haibin Zhang

DOI: https://doi.org/10.1093/ietcom/e90-b.2.377

2007-02-01

IEICE Transactions on Communications

Abstract:Iterative receivers, which perform MMSE detection and decoding iteratively, can provide significant performance improvement compared with noniterative method. However, due to the high computational cost and numerical instability, conventional MMSE detection using a priori information can not be implemented in hardware. In this letter, we propose a newly-built iterative receiver which is division-free and numerically stable, and then we analyze the results of a fixed-point simulation and present the hardware implementation architecture.
The role of persisting antigen in the development of immunological memory.

J. Cerottini,Z. Trnka

DOI: https://doi.org/10.1159/000230257

International Archives of Allergy and Applied Immunology

Abstract:
Selecting, Inbreeding, Recombining, and Hybridizing Commercial Yeasts

C. C. Lindegren,G. Lindegren

DOI: https://doi.org/10.1128/jb.46.5.405-419.1943

IF: 3.2

1943-11-01

Journal of Bacteriology

Abstract:The first step in a breeding program is the selection of strains with different useful characteristics. A few of the specific requirements of a good bakers' yeast generally recognized by commercial producers are: (1) Keeping quality. A good yeast does not autolyze nor lose viability excessively when held in a cake for a few days at room temperature. (2) Baking strength. A good yeast causes dough to rise quickly. (3) High yield. A good yeast transforms the maximum amount of nutrients in the fermentors into yeast in the shortest possible time. Different strains of bakers' yeast vary in these and other properties. The second step in a breeding program is the intensive inbreeding of each of the chosen strains. Successful inbreeding accomplishes two results: (1) it intensifies the desirable character, (2) it eliminates undesirable recessive genes and makes the breeding stock homozygous for the desirable traits. Some good breeding stocks do not give outward manifestations of their excellence because the inbreeding process which has intensified their vigor in one character may have reduced their vigor in other respects. The third step is the combination of the different desirable qualities of various stocks by hybridizing. The results of hybridizing are not predictable. One reason is that inbreeding operates at random in the selection of modifying genes. Another reason is that certain characters may be mutually exclusive. For example, it is possible that high yield may result from a physiological mechanism that reduces baking strength, and a given stock may not be able to excel in both characteristics. In the most favorable condition the hybrid may be superior to the two parents in the traits for which the parents were selected; in the most unfavorable condition the hybrid may be inferior to both parents in the respective traits. In yeasts, the hybrid can be propagated asexually. This means that the problem is simpler than in the higher plants such as maize, for in maize each generation is produced sexually and the maize hybrid deteriorates on propagation due to the segregation of the characters combined in the hybrid. In yeast propagation, sexual reproduction ordinarily occurs only under special conditions and it should be possible to maintain the hybrid combination indefinitely by asexual vegetative propagation.
Corrigendum to “Exploring comorbidity and pharmacological treatment patterns in psoriasis - A retrospective population-based cross-sectional study”

DOI: https://doi.org/10.1177/26335565231223601

2023-12-01

Journal of Multimorbidity and Comorbidity

Abstract:[This corrects the article DOI: 10.1177/26335565231212336.].
Corrigendum to Tildrakizumab Inadequate Responders Switching to an Alternative IL-23 Inhibitor: A Case Series

DOI: https://doi.org/10.1177/24755303231195883

Abstract:[This corrects the article DOI: 10.1177/24755303211037308.].
Corrigendum to Prevalence of Utilization Management Policies Among the Psoriatic Disease Community: Results From the 2019 National Psoriasis Foundation Advocacy Survey

DOI: https://doi.org/10.1177/24755303231195870

Abstract:[This corrects the article DOI: 10.1177/2475530320956602.].
Corrigendum: Dose reduction of biologics in patients with plaque psoriasis: a review

C. A. M. van Riel,C. A. J. Michielsens,M. E. van Muijen,L. S. van der Schoot,J. M. P. A. van den Reek,E. M. G. J. de Jong

DOI: https://doi.org/10.3389/fphar.2024.1505626

IF: 5.6

2024-10-15

Frontiers in Pharmacology

Abstract:This article is a correction to: Dose reduction of biologics in patients with plaque psoriasis: a review

pharmacology & pharmacy
Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

DOI: https://doi.org/10.1177/20542704241260192

2024-06-02

JRSM Open

Abstract:[This corrects the article DOI: 10.1177/20542704221148059.].
Factor‐VIII Activity and Antigen, Platelet Count and Biochemical Changes after Adrenoceptor Stimulation

G. Ingram,R. V. Jones,E. Hershgold,K. Denson,J. Perkins

DOI: https://doi.org/10.1111/j.1365-2141.1977.tb00565.x

1977-01-01

British Journal of Haematology

Abstract:Adrenaline, isoprenaline and salbutamol were administered by intravenous infusion to human subjects. Isoprenaline was covered with practolol in an attempt to reduce the unpleasantness of the circulatory effects. Changes were recorded in pulse rate and blood pressure, and in blood levels of factors V, VIII, X, XI and XII, platelet count, lactate, pyruvate, potassium and free fatty acids. Factor VIII was studied by clotting assays, by reactions with two rabbit antisera and two human antibodies, and by desulphated agarose chromatography. At the rate at which they were administered, all three drugs increased the pulse rate by 20–40 beats/min. Factor VIII rose c. 2.5 x with adrenaline but only c. 1.5 x with isoprenaline and salbutamol; but other clotting factors did not alter. Chromatography provided no evidence of a change in the size of the molecule carrying factor‐VIII clotting activity. The rate of clearance of the heightened plasma activity could not be shown to differ from that of ‘ordinary’factor VIII infused into haemophiliacs. The platelet count rose after adrenaline, fell after salbutamol and did not change significantly after isoprenaline. Among the biochemical responses, the only significant difference between the drugs was that lactate rose after adrenaline and salbutamol but did not change after isoprenaline.
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg,Joseph F. Merola,Knut Schäkel,Luis Puig,Patrick D. Mahar,Isabella Yali Wang,Imre Pavo,Christopher Schuster,Christopher E. M. Griffiths

DOI: https://doi.org/10.3389/fmed.2023.1171132

IF: 3.9

2023-03-10

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.1092688.].

medicine, general & internal
Gold(I)-catalyzed synthesis of 1,5-benzodiazepines directly from o-phenylenediamines and alkynes.

Jianqiang Qian,Yunkui Liu,J. Cui,Zhen-yuan Xu

DOI: https://doi.org/10.1021/jo300543n

2012-04-23

Abstract:A unique gold(I)-catalyzed highly atom-economic synthesis of 1,5-benzodiazepines directly from o-phenylenediamines and alkynes has been achieved for the first time.
Type I hyperlipoproteinaemia.

W. Brown,H. Greten

DOI: https://doi.org/10.1016/S0300-595X(73)80027-1

1973-03-01

Clinics in Endocrinology and Metabolism

Abstract:
Corrigendum to "The treatment of primary biliary cholangitis: from shadow to light"

DOI: https://doi.org/10.1177/17562848241277276

2024-08-31

Abstract:[This corrects the article DOI: 10.1177/17562848241265782.].
Corrigendum to Assessing the Effect of Demographic Background on Barriers to Seek Medical Attention for Psoriasis

DOI: https://doi.org/10.1177/24755303231195869

Abstract:[This corrects the article DOI: 10.1177/2475530320950265.].

Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab

Comparison of exertion required to perform standard and active compression-decompression cardiopulmonary resuscitation.

Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series

Depth profiling the whispering gallery modes in TiO2:Eu3+ microspheres using cathode luminescence.

Corrigendum to Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data

Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers.

Newly-Built Iterative Receiver and Hardware Implementation for V-BLAST

The role of persisting antigen in the development of immunological memory.

Selecting, Inbreeding, Recombining, and Hybridizing Commercial Yeasts

Corrigendum to “Exploring comorbidity and pharmacological treatment patterns in psoriasis - A retrospective population-based cross-sectional study”

Corrigendum to Tildrakizumab Inadequate Responders Switching to an Alternative IL-23 Inhibitor: A Case Series

Corrigendum to Prevalence of Utilization Management Policies Among the Psoriatic Disease Community: Results From the 2019 National Psoriasis Foundation Advocacy Survey

Corrigendum: Dose reduction of biologics in patients with plaque psoriasis: a review

Corrigendum to "Long recurrence-free survival of localized rectal melanoma after abdominoperineal resection in comparison to partial excision and highlighting the place of immunotherapy: A case report."

Factor‐VIII Activity and Antigen, Platelet Count and Biochemical Changes after Adrenoceptor Stimulation

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Gold(I)-catalyzed synthesis of 1,5-benzodiazepines directly from o-phenylenediamines and alkynes.

Type I hyperlipoproteinaemia.

Corrigendum to "The treatment of primary biliary cholangitis: from shadow to light"

Corrigendum to Assessing the Effect of Demographic Background on Barriers to Seek Medical Attention for Psoriasis